SCHEMBL17599341

SCHEMBL17599341

Cc1nc(C)c(S(=O)(=O)Nc2ccc(-c3cc(C(=O)O)ccc3F)c3ccccc23)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.43
KEAP1 Q14145 1/20 0.41
PTK2B Q14289 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KMT2A Q03164 1/20 0.40
SLC16A3 O15427 1/20 0.39
BRAF P15056 1/20 0.39
PFKFB4 Q16877 3/20 0.38
ACLY P53396 2/20 0.38
CMA1 P23946 1/20 0.37
FABP5 Q01469 1/20 0.37
PFKFB3 Q16875 1/20 0.37
PTGFR P43088 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA5A P35218 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599326 0.84 KEAP1 (0.46) FABP4KEAP1SMN1; SMN2ACLYPTGFR
SCHEMBL17599343 0.84 KEAP1 (0.46) KEAP1KMT2APFKFB4ACLYPFKFB3
SCHEMBL17599385 0.81 TSHR (0.47) FABP4PTK2BSMN1; SMN2KMT2ASLC16A3
SCHEMBL17613337 0.80 PFKFB3 (0.63) KEAP1PFKFB4CMA1PFKFB3
SCHEMBL17599370 0.79 ALDH1A1 (0.53) FABP4KEAP1PTK2BSMN1; SMN2KMT2A
SCHEMBL17599305 0.79 ACLY (0.55) FABP4PTK2BSMN1; SMN2SLC16A3ACLY
SCHEMBL17599320 0.78 SMN1; SMN2 (0.54) FABP4PTK2BSMN1; SMN2KMT2ASLC16A3
SCHEMBL17599411 0.77 TDP1 (0.55) FABP4PTK2BSMN1; SMN2SLC16A3ACLY
SCHEMBL17599333 0.77 PTK2B (0.52) FABP4PTK2BSMN1; SMN2KMT2ASLC16A3
SCHEMBL17599390 0.76 KEAP1 (0.56) KEAP1SMN1; SMN2KMT2ASLC16A3PFKFB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed